MitoTracker Deep Red (MTDR) Is a Metabolic Inhibitor for Targeting Mitochondria and Eradicating Cancer Stem Cells (CSCs), With Anti-Tumor and Anti-Metastatic Activity In Vivo

Overview of attention for article published in Frontiers in oncology, July 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter: 4 X users

patent: 1 patent

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 30 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 7,385 followers.

@genehackrman A quick lit search turned up this paper: https://t.co/BPZ0kbHsDG

01 Nov 2022

Reply Repost Favourite

Dye or Drug ?? MitoTracker Deep Red (MTDR) Is a Metabolic Inhibitor for Targeting Mitochondria and Eradicating #CancerStemCells With Anti-Tumor and Anti-Metastatic Activity In Vivo https://t.co/EnTbjcAARj

19 Mar 2022

Reply Repost Favourite

⭐#9: MitoTracker Deep Red (MTDR) Is a Metabolic Inhibitor for Targeting #Mitochondria and Eradicating Cancer Stem Cells (CSCs), With Anti-Tumor and Anti-Metastatic Activity In Vivo 👨‍⚕️👩‍⚕️ Sargiacomo C et al 👉 https://t.co/NbREKUGWba @SalfordUni #cancerm

23 Dec 2021

Reply Repost Favourite

RT @FrontOncology: New research: MitoTracker Deep Red (MTDR) Is a Metabolic Inhibitor for Targeting Mitochondria and Eradicating Cancer Ste…

02 Aug 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.